Heartbeam Inc BEAT.OQ reported a quarterly adjusted loss of 19 cents per share for the quarter , lower than the same quarter last year, when the company reported EPS of -13 cents. The mean expectation of two analysts for the quarter was for a loss of 17 cents per share. Wall Street expected results to range from -18 cents to -17 cents per share.
Reported revenue was zero; analysts expected zero.
Heartbeam Inc's reported EPS for the quarter was a loss of 19 cents.
The company reported a quarterly loss of $4.98 million.
Heartbeam Inc shares had risen by 0.4% this quarter and lost 0.9% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 6.1% in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."
The average consensus recommendation for the advanced medical equipment & technology peer group is "hold."
Wall Street's median 12-month price target for Heartbeam Inc is 5.00
This summary was machine generated from LSEG data November 8 at 09:01 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Sep. 30 2024 | -0.17 | -0.19 | Missed |
Jun. 30 2024 | -0.16 | -0.19 | Missed |
Mar. 31 2024 | -0.15 | -0.17 | Missed |
Dec. 31 2023 | -0.13 | -0.15 | Missed |
Comments